Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3161 – 3180
of
3979
Etravirine (Intelence, ETR)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nnrtis-etravirine-intelence
Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/nucleoside-and-nucleotide-analogue-reverse-transcriptase-inhibitors-nrtis
Zidovudine
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/zidovudine
Figures
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/figures
Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-nrti
Toxoplasma gondii Encephalitis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/toxoplasma-gondii
Pharmacoenhancers
https://clinicalinfo.hiv.gov/guidelines/perinatal/pharmacoenhancers
Ritonavir (Norvir, RTV)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-pharmacoenhancers-ritonavir-norvir
Pregnancy and Postpartum HIV Testing and Identification of Perinatal and Postnatal HIV Exposure
https://clinicalinfo.hiv.gov/guidelines/perinatal/maternal-hiv-testing-identification-exposure
Overview
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-overview
Indinavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/indinavir
Tests for Initial Assessment and Monitoring of People with HIV
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/tests-initial-assessment-follow-up
Special Patient Populations
https://clinicalinfo.hiv.gov/guidelines/adult-and-adolescent-arv/special-patient-populations
Special Populations: Substance Use Disorders and HIV
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-substance-use
Tables
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/tables
Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-5-significant-drug
Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/plasma-hiv-1-rna-cd4-monitoring
Overview
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/overview
Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs
https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-long-term-follow-up-exposed-arv-drugs
Financial Disclosure
https://clinicalinfo.hiv.gov/guidelines/perinatal/financial-disclosure
Pagination
First page
«
Previous page
‹
…
Page
155
Page
156
Page
157
Page
158
Current page
159
Page
160
Page
161
Page
162
Page
163
…
Next page
›
Last page
»